– Hahn F, Hamilton ST, Wangen C, Wild M, Kicuntod J, Brückner N, Follett JEL, Herrmann L, Kheimar A, Kaufer B, Rawlinson WD, Tsogoeva SB, Marschall M (2021) Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity. International Journal of Molecular Sciences. 22(23), 12858
– Hamilton ST, Hahn F, Sonntag E, Marschall M, Rawlinson WD (2021). A placental specific miRNA miR-517a-3p exerts anti-human cytomegalovirus activity. Placenta. 112: 62-65
Receptors in host pathogen interactions between human cytomegalovirus and the placenta during congenital infection. Reviews in Medical Virology. doi: 10.1002/rmv.2233 (*Joint First Authors)
– Hamilton ST, Marschall M, Rawlinson WD (2021). Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy. Antimicrobial Agents and Chemotherapy. 65(1):e01627-20
– Bartlett AW, Hamilton ST, Shand AW, Rawlinson WD (2020). Fetal therapies for cytomegalovirus: what to tell prospective parents. Prenatal Diagnosis.40(13):1681-1692
– Naing Z*, Hamilton ST*, van Zuylen WJ, Scott G, Rawlinson WD (2020). Differential expression of PDGF receptor-alpha in human placental trophoblasts leads to different entry pathways by human cytomegalovirus strains. Nature Scientific Reports. 10(1):1082 (*Joint First Authors)
– Häge S, Horsch D, Stilp AC, Kicuntod J, Müller R, Hamilton ST, Egilmezer E, Rawlinson WD, Stamminger T, Sonntag E, Marschall M (2020). A Quantitative Nuclear Egress Assay to Investigate the Nucleocytoplasmic Capsid Release of Human Cytomegalovirus. Journal of Virological Methods. 283:113909
– Singh K, Palasanthiran P,Hamilton ST, Rawlinson WD (2020). Cotton Wool Balls Are an Effective Urine Collection Tool for CMV PCR for Diagnosing Congenital Cytomegalovirus Infection. Pathology. 52(4): 504506
– Wong DD, van Zuylen WJ, Hamilton ST, Steingruber M, Sonntag E, Marschal M, Rawlinson WD (2019). Patient-derived cytomegaloviruses with different ganciclovir sensitivities from UL97 mutation retain their replication efficiency and some kinase activity in vitro. Antimicrobial Agents and Chemotherapy. 63(9): e02425-18
– Shand A, Palasanthiran P, Rawlinson WD (2019) Pre-conception care: an important yet underutilized preventive care strategy. Medical Journal of Australia. 210(9):429
– Lazzaro A, Vo ML, Zelter J, Rawlinson WD, Nassar N, Daly K, Lainchbury A, Shand A (2019). Knowledge of congenital cytomegalovirus (CMV) in pregnant women in Australia is low, and improved with education. Australia and New Zealand Journal of Obstetrics and Gynaecology. doi: 10.1111/ajo.12978
– Wong DD, van Zuylen WJ, Craig ME, Rawlinson WD. (2018). Systematic review of ganciclovir pharmacodynamics during the prevention of cytomegalovirus infection in adult soild organ transplant recipients. Reviews in Medical Virology. 29(2):e2023
– Huynh KT, van Zuylen WJ, Ford CE, Rawlinson WD (2018). Selective modulation of Wnt-binding receptor tyrosine kinase ROR2 expression by human cytomegalovirus regulates trophoblast migration. Journal of General Virology 100(1): 99-104
– Hamilton ST, Hutterer C, Egilmezer E, Steingruber M, Milbradt J, Marschall M, Rawlinson WD (2018). Human cytomegalovirus utilises cellular dual-specificity tyrosine phosphorylation-regulated kinases during placental replication. Placenta. 72-73:10-19
– Hahn F, Hutterer C, Henry C, Hamilton ST, Strojan H, Kraut A, Schulte U, Schutz M, Kohrt S, Wangen C, Pfizer J, Coute Y, Rawlinson WD, Strobl S, Marschall M. (2018). Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusua mechanism of antiviral activity. Antiviral Research. 159: 84-94
– Zheng QY, Huynh KT, van Zuylen WJ, Craig ME, Rawlinson WD (2018). Cytomegalovirus infection in day care centres: A systematic review and meta-analysis of prevalence of infection in children. Reviews in Medical Virology. 29(1): e2011
– Bartlett AW, Hall BM, Palasanthiran P, McMullan B, Shand AW, Rawlinson WD (2018). Recognition, treatment, and sequelae of congenital cytomegalovirus in Australia: An observational study. Journal of Clinical Virology. 108:121-125.
– Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A; The Transplantation Society International CMV Consensus Group (2018). The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation 102(6): 900-931
– Rawlinson WD, Palasanthiran P, Hall B, Al Yazidi L, Cannon MJ, Cottier C, van Zuylen WJ, Wilkinson M. (2018). Neonates with congenital Cytomegalovirus and hearing loss identified via the universal newborn hearing screening program. Journal of Clinical Virology 102: 110-115.
– Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doure S, Gibson L, Giles ML, Greenlee J, Hamilton ST, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand AW, van Zuylen WJ. (2017). Congenital cytomegalovirus infection in pregnancy and the neonate: Consensus recommendations for prevention diagnosis and therapy. Lancet Infectious Diseases. 17(6):e177-e188
– Hutterer C, Milradt J, Hamilton ST, Zaja M, Leban J, Henry C, Vitt D, Steingruber M, Sonntag E, Zeittrager I, Bahsi H, Stamminger T, Rawlinson WD, Strobl S, Marschall M. (2017). Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity. Antiviral Research. 9(143):113-121
– Van Zuylen WJ, Zheng J, Hamilton ST, Egilmezer E, Craig M, Gralton J, Rawlinson WD (2017). Prevalence of cytomegalovirus carriage among childcare staff. Journal of Paediatrics and Child Health. 53(7):724
– Ornelas AMM, Pezzuto P, Silveira PP, Melo FO, Ferreira TA, Oliveira-Szejnfeld PS, Leal JI, Amorim MM, Hamilton ST, Rawlinson WD, Cardoso CC, Nixon, DF, Tanuri A, Melo AS, Aguiar RS. (2017). Immune activation in amniotic fluid from zika virus associated microcephaly. Annals of Neurology. 81(1):152-156.
– Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P (2017). Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: A systematic review. Reviews in Medical Virology. doi: 10.1002/rmv.1938
– Hutterer C, Hamilton ST, Steingruber M, Zeittrager I, Bahsi H, Thuma N, Naing Z, Orfi Z, Orfi L, Socher E, Sticht H, Rawlinson WD, Chou S, Haupt VJ, Marschall M. (2016). The chemical class of quinazoline compounds provides a core structure for the design of anticytomegaloviral kinase inhibitors. Antiviral Research. 134:130-43
– Sonntag E, Hamilton ST, Bahsi H, Wagner S, Jonjic S, Rawlinson WD, Marschall M, Milbradt J. (2016). Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC components. Journal of General Virology. 97(7):1676-85
– Rawlinson WD, Hamilton ST, van Zuylan WJ. (2016). Update on treatment of cytomegalovirus infection in pregnancy and of the newborn with congenital cytomegalovirus. Current Opinions in Infectious Diseases. 29(6):615-24
– Graf L, Feichtinger S, Naing Z, Hutterer C, Milbradt J, Webel R, Wagner S, Scott G, Hamilton ST, Rawlinson WD, Stamminger T, Thomas M, Marschall M. (2016). New insights into the phosphorylation-regulated intranuclear localization of human cytomegalovirus pUL69 mediated by cylin-dependent Kinsaes (CDKs) and viral CDK ortholog pUL97. Journal of General Virology. 97(1):144-51.
– Naing Z, Scott GM, Hamilton ST, van Zuylen W, Shand A, Basha J, Hall B, Craig ME, Rawlinson WD. (2016). Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. ANZJOG. 56(1):9-18
– Cameron BM, Kennedy SE, Rawlinson WD, Mackie FE. (2016). The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children. Pediatr Transplant. 21(1).
– van Zuylen WJ, Rawlinson WD, Ford CE (2016). The Wnt pathway: a key network in cell signalling dysregulated by viruses. Reviews in Medical Virology. 26(5):340-55.
– Rogers N. (2015). A dormant danger: New therapies target a ubiquitous pathogen known as cytomegalovirus. Nature Medicine 21:1104-1105.
– Hamilton ST, Hutterer C, Marschall M. (2015). Therapeutics to prevent congenital CMV during pregnancy – what is available now and in the future? Microbiology Australia, vol. 36, no. 4. Doi 10.1071/MA15057
– Naing Z, Webel R, Hamilton ST, Schmeiser C, Scott GM, Marschall M, Rawlinson WD. (2015). Stimulatory effects of human cytomegalovirus tegument protein pp71 lead to increased expression of CCL2 (MCP-1) during infection. J Gen Virol. 96(7):1855-1862
– van Zuylen WJ, Ford CE, Wong DD, Rawlinson WD (2015). Human Cytomegalovirus Modulates Expression of Noncanonical Wnt Receptor ROR2 To Alter Trophoblast Migration. Journal of Virology. 90(2): 1108-15.
– Hamilton ST, van Zuylen W, Shand A, Scott GM, Naing Z, Hall B, Craig ME, Rawlinson WD. (2014). Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. Reviews in Medical Virology. 24(6):420-33
– Milbradt J, Kraut A, Hutterer C, Sonntag E, Schmeiser C, Ferro M, Wagner S, Lenac T, Claus C, Pinkert S, Hamilton ST, Rawlinson WD, Sticht H, Coute´ Y, and Marschall M. (2014). Proteomic Analysis of the Multimeric Nuclear Egress Complex of Human Cytomegalovirus. Molecular and Cellular Proteomics. 13(8):2132-46.
– Hamilton ST, Milbradt J, Marschall M, Rawlinson WD. (2014). Human Cytomegalovirus Replication is Strictly Inhibited by siRNAs Targeting UL54, UL97 or UL122/123 Gene Transcripts. PLoS ONE 9(6): e97231.
– van Zuylen W, Hamilton ST, Naing Z, Hall B, Shand A, Rawlinson WD. (2014). Congenital cytomegalovirus infection: Clinical presentation, epidemiology, diagnosis and prevention. Obstetric Medicine. 7(4):140-46.
– Basha J, Iwasenko JM, Robertson P, Craig ME, Rawlinson WD (2013) CMV seropositivity is related to socioeconomic status in pregnant women but not in children in Australia. Journal of Paediatrics and Child Health 50(5):368-72.
– Rajasekariah H, Scott G, Robertson PW, Rawlinson WD (2013) Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots. Journal of Medical Virology. 85(2):315-319
– Hamilton ST, Scott GM, Naing Z, Iwasenko J, Hall B, Graf N, Arbuckle N, Craig ME, Rawlinson WD (2013) Human cytomegalovirus induces cytokine changes in the placenta with implications for adverse pregnancy outcomes. PLoS One 7(12): e52899.
– Craig ME, Stein H, Nair S, Rawlinson WD (2013) Viruses and type 1 diabetes: a new look at an old story. Paedeatiric Diabetes 14(3):149-58
– Cotin S, Calliste CA, Mazeron M-C Hantz S., Duroux S., Rawlinson WD, Ploy M-C, Alain S (2012) Eight Flavonoids And Their Potential As Inhibitors Of Huma Cytomegalovirus Replication. Antiviral Research 96(2):181-186
– Scott GM, Chow SSW, Craig ME, Pang C, Hall B, Wilkins M, Jones CA, Lloyd AR, Rawlinson WD (2012) Cytomegalovirus infection during pregnancy with materno-fetal transmission induces a pro-inflammatory cytokine bias in placenta and amniotic fluid. Journal of Infectious Diseases 205(8):1305-1310
– Yeung WCG, Al-Shaheeb A, Catteau J, Howard N, Rawlinson WD, Craig ME (2012) Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile. Diabetes 61(6):1500-1508
– Iwasenko JM, Howard J, Arbuckle S, Graf N, Hall B, Craig ME, Rawlinson WD (2011) Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. Journal of Infectious Diseases 203:1526–33 (with editorial commentary by Pereira L (2011) Have We Overlooked Congenital Cytomegalovirus Infection as a Cause of Stillbirth? Journal of Infectious Diseases 203:1510-12)
— Lusthaus, J.A., Kim, P., Steller, A.K., Naing, Z., Scott, G.M., Rawlinson, W.D., Lyon P. Robinson, L.P., Peter J. McCluskey, P.J., Wechsler, A.W. (2010). Successful corneal autograft following clearance of anterior chamber cytomegalovirus with oral valganciclovir in a patient with multiple failed corneal allografts. Cornea.
– Rechter, S. Scott, G.M., Eickhoff, J., Zielke, K., Auerochs, S., Müller, R., Stamminger, T., Rawlinson, W.D., Marschall, M. (2009). Cyclin-dependent kinases phosphorylate the cytomegalovirus RNA export protein pUL69 and modulate its nuclear localization and activity. Journal of Biological Chemistry 284:8605-8613
– Iwasenko, J.M., Scott, G.M., Rawlinson, W.D., Keogh, A., Mitchell, D., Chou, S. (2009) Successful valganciclovir treatment of post-transplant cytomegalovirus infection in the presence of UL97 mutation N597D. Journal of Medical Virology 81:507-510.
– Scleiss, M., Eickhoff, J., Auerochs, S., Leis, M, Abele, S., Rechter, S., Choi, Y., Anderson, J., Scott, G., Rawlinson, W., Michel, D., Ensminger, S., Klebl, B., Stamminger, T., Marschall, M. (2008). Protein kinase inhibitors of the quinazalone class exert anti-cytomegaloviral activity in vitro and in vivo. Antiviral Research 79(1):49-61.
– Scott, G.M., Steller, A., Wang, S., Teng, K.W.W. and Chow, S.S.W. (2008) Pathogenesis of cytomegalovirus infection in pregnancy. Microbiology Australia 29(4): 200-203
– Scott G.M., Weinberg A., Rawlinson W.D. and Chou S. (2007) Multi-Drug Resistance Conferred by Novel DNA Polymerase Mutations in Human Cytomegalovirus Isolates. Antimicrobial Agents and Chemotherapy 51(1): 89-94.
– Iwasenko J.M., Scott G.M., Ziegler J.B., Rawlinson W.D. (2007) Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child. Journal of Clinical Virology 40(2):152-155.
– Scalzo, A.A., Corbett, A.J., Rawlinson, W.D., Scott, G.M. and Degli-Esposti, M.P. (2007) The interplay between host and virus factors in shaping the outcome of cytomegalovirus infection. Immunology and Cell Biology 85: 46-54.
– Chow S.S.W., Craig M.E., Jacques C.F.H., Hall, B., Catteau, J., Munro S.C., Scott G.M., Camaris, C., McIver C.J., Rawlinson W.D. (2006). Correlates of placental infection with cytomegalovirus, parvovirus B19 or human herpesvirus. Journal of Medical Virology 78: 747-756
– Scott, G.M., Ng, H.-I., Morton, C.J., Parker, M.W., Rawlinson, W.D. (2005) Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.Journal of General Virology, 86: 2141-2151.
– Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson W.D. (2005). Diagnosis of and screening for cytomegalovirus infection in pregnant women. Journal of Clinical Microbiology;43(9):4713-4718.
– Munro SC, Trincado D, Hall B, Rawlinson WD. (2005) Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia. Journal of Paediatrics & Child Health 41(8):449-452.
– Trincado DE, Munro SC, Camaris C, Rawlinson WD. (2005) Highly Sensitive Detection and Localization of Maternally Acquired Human Cytomegalovirus in Placental Tissue by In Situ Polymerase Chain Reaction. Journal of Infectious Diseases 192(4):650-657.
– McIver, C.J., Roberts, J., Jacques, C., Chow, S., Scott, G.M., Munro, S.C., Craig, M.E., Rawlinson, W.D. (2005) Diagnosis of congenital infections and common viral pathogens using multiplex PCR (mPCR). Journal of Clinical Microbiology; 43 (10): 5102-5110.
